Modern coronary surgery, the SYNTAX trial and updated guidelines

Posted by: drchasrani on: June 14, 2012

CABG remains the main stay treatment for triple vessel disease. Not only it helps revascularisation but also prevents MI, thus increasing lifespan.                                            Team@CMHF

Coronary artery bypass grafting (CABG), a modern and safe procedure, is considered the therapy of choice in the care of patients with multi-vessel disease.

The 3-year results of the SYNTAX trial not only showed surgical advantages in terms of repeat revascularisation, but the results also demonstrated significant surgical benefit for myocardial infarction and survival rates.

PCI tends to be a comparable therapeutic option only in certain cases of left main stem lesions or multi-vessel disease.



Leave a Reply

Your email address will not be published. Required fields are marked *


CMHF Accredited by Maharashtra Medical Council

Subscribe to our Posts

Enter your email address:

  • drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
  • rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
  • nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards

Calculate Your Body Mass Index

Check your Body Mass Index »

    Strawberry - 31 kcal in 100g
    Strawberry - 31 kcal in 100g
    by Noni